Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
We evaluate long-term return potential across index funds to help you identify candidates with the strongest growth prospects.
28,522 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A leading retailer is quietly deploying AI to sharpen efficiency and customer service, signaling a stealth AI play fo...
A failing satellite firm pivoted by selling spectrum to SpaceX, triggering a sharp stock surge and turning investor b...
A major investment move puts Clearwater Analytics stock lands squarely in the spotlight. With 77% ARR growth and chat...
In a surprising turn, anthropic’s claude overtakes chatgpt on the App Store as users rally against OpenAI. The move c...
July can bring clear catalysts for Disney stock investors. This guide highlights three dates to watch, explains why t...
SpaceX stock surged after its open, then cooled as investors digest fundamentals and macro conditions. This article e...
A personal-finance story about a costly legal battle forces a rethink on whether to accept a partner's financial supp...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
Micron's stock jumped more than 600% in a year, sparking a lively debate about a possible stock split. This guide bre...
Vipshop (VIPS) has carved a niche in discount e-commerce. This guide breaks down what to watch in the 2025 earnings s...
Oracle just posted its strongest quarter ever with massive cloud backlog, yet investors face a capital-heavy path ahe...